Blueprint Medicines Corp (BPMC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2022 | 09-2022 | 06-2022 | 03-2022 | 12-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 119,709 | 291,430 | 173,399 | 37,199 | 209,948 |
| Marketable Securities | 825,283 | 845,535 | 679,712 | 549,627 | 267,166 |
| Receivables | 36,938 | 21,915 | 29,410 | 32,598 | 37,030 |
| Inventories | 29,697 | 35,253 | 35,454 | 30,145 | 21,817 |
| TOTAL | $1,046,651 | $1,227,665 | $952,179 | $687,244 | $554,025 |
| Non-Current Assets | |||||
| PPE Net | 33,344 | 33,454 | 32,987 | 31,110 | 30,700 |
| Investments And Advances | 161,269 | 83,464 | 94,048 | 306,525 | 557,529 |
| Other Non-Current Assets | 108,638 | 113,809 | 113,232 | 118,428 | 109,971 |
| TOTAL | $303,251 | $230,727 | $240,267 | $456,063 | $698,200 |
| Total Assets | $1,349,902 | $1,458,392 | $1,192,446 | $1,143,307 | $1,252,225 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 16,851 | 15,290 | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 2,729 | 4,233 | 15,053 | 17,961 | 8,333 |
| Accrued Expenses | 131,123 | 120,763 | 119,282 | 100,698 | 121,829 |
| Other current liabilities | 17,285 | 20,479 | 5,512 | N/A | N/A |
| TOTAL | $183,234 | $175,510 | $158,760 | $137,025 | $149,765 |
| Non-Current Liabilities | |||||
| Long Term Debt | 122,232 | 123,060 | N/A | N/A | N/A |
| Deferred Revenues | 4,667 | 4,629 | 9,478 | 9,604 | 11,510 |
| Other Non-Current Liabilities | 516,135 | 507,520 | 273,275 | 110,895 | 106,659 |
| TOTAL | $651,991 | $642,575 | $285,936 | $124,616 | $131,725 |
| Total Liabilities | $835,225 | $818,085 | $444,696 | $261,641 | $281,490 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 59,984 | 59,831 | 59,720 | 59,571 | 59,203 |
| Common Shares | 60 | 60 | 60 | 60 | 59 |
| Retained earnings | -1,832,958 | -1,674,312 | -1,541,149 | -1,381,440 | -1,275,441 |
| Other shareholders' equity | -10,443 | -14,826 | -14,248 | -12,110 | -4,133 |
| TOTAL | $514,677 | $640,307 | $747,750 | $881,666 | $970,735 |
| Total Liabilities And Equity | $1,349,902 | $1,458,392 | $1,192,446 | $1,143,307 | $1,252,225 |